Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrovent in Exercise-induced Bronchoconstriction in Athletes
NCT01691079Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Dec 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ipratropium bromide in bronchospasm, sponsored by University of California, San Francisco. Started Dec 2012; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
bronchospasm
Beyond the preview
Go deeper on NCT01691079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691079.